Wu Liz Y, Di Carlo Dino, Lee Luke P
Biomolecular Nanotechnology Center, Berkeley Sensor and Actuator Center, Department of Bioengineering, University of California, Berkeley, CA 94720, USA.
Biomed Microdevices. 2008 Apr;10(2):197-202. doi: 10.1007/s10544-007-9125-8.
Creating multicellular tumor spheroids is critical for characterizing anticancer treatments since it may provide a better model than monolayer culture of in vivo tumors. Moreover, continuous dynamic perfusion allows the establishment of physiologically relevant drug profiles to exposed spheroids. Here we present a physiologically inspired design allowing microfluidic self-assembly of spheroids, formation of uniform spheroid arrays, and characterizations of spheroid dynamics all in one platform. Our microfluidic device is based on hydrodynamic trapping of cancer cells in controlled geometries and the formation of spheroids is enhanced by maintaining compact groups of the trapped cells due to continuous perfusion. It was found that spheroid formation speed (average of 7 h) and size uniformity increased with increased flow rate (up to 10 microl min(-1)). A large amount of tumor spheroids (7,500 spheroids per square centimeter) with a narrow size distribution (10 +/- 1 cells per spheroid) can be formed in the device to provide a good platform for anticancer drug assays.
创建多细胞肿瘤球体对于表征抗癌治疗至关重要,因为它可能比体内肿瘤的单层培养提供更好的模型。此外,连续动态灌注能够为暴露的球体建立生理相关的药物分布。在此,我们展示了一种受生理启发的设计,该设计能够在一个平台上实现球体的微流体自组装、均匀球体阵列的形成以及球体动力学的表征。我们的微流体装置基于在受控几何形状中对癌细胞的流体动力学捕获,并且由于连续灌注使捕获的细胞保持紧密聚集,从而增强了球体的形成。研究发现,球体形成速度(平均7小时)和尺寸均匀性随着流速增加(高达10微升/分钟)而提高。在该装置中可以形成大量尺寸分布狭窄(每个球体10±1个细胞)的肿瘤球体(每平方厘米7500个球体),为抗癌药物检测提供了一个良好的平台。